Search Results - "Dusheiko, G.M"

P1119 EARLY VIRAL KINETICS DO NOT PREDICT TREATMENT OUTCOME WITH SOFOSBUVIR + RIBAVIRIN FOR 12 OR 24 WEEKS IN HCV GENOTYPE 2/3 PATIENTS IN THE VALENCE TRIAL by Zeuzem, S, Dusheiko, G.M, Colombo, M, Flisiak, R, Hyland, R.H, Illeperuma, A, Brainard, D.M, Symonds, W.T, McHutchison, J.G, Weiland, O, Reesink, H.W, Brown, A, Pol, S, Hezode, C, Esteban, R

Get full text

73 WORLDWIDE EXPERIENCE TREATING CHRONIC HEPATITIS C (CHC) WITH PEGINTERFERON ALFA/RIBAVIRIN: FINAL RESULTS FROM 7163 NAIVE, MONO-INFECTED PATIENTS ENROLLED IN THE LARGE MULTINATIONAL PROPHESYS COHORT STUDY by Marcellin, P, Cheinquer, H, Curescu, M, Dusheiko, G.M, Ferenci, P, Horban, A, Jensen, D, Lengyel, G, Mangia, A, Ouzan, D, Puoti, M, Rodriguez-Torres, M, Shiffman, M.L, Schmitz, M, Tatsch, F, Rizzetto, M

Get full text

1224 TIMING AND CHARACTERISTICS OF DRUG RESISTANCE MUTATIONS (DRMS) IN CHRONIC HEPATITIS C PATIENTS DURING AND AFTER TREATMENT WITH PROTEASE INHIBITOR THERAPY AT A SINGLE CENTRE by Velazquez, C, Macartney, M, Irish, D, Tanwar, S, Trembling, P, Hogan, B, Catt, J, Glasgow, S, Ju, M, Moore, M.T, Hains, M, Smith, B, Suri, D, Jacobs, M.G, Oben, J, Smith, P, Booth, C, Bridge, S, Garcia, A, McCormick, A, Nastouli, E, Dusheiko, G.M, Rosenberg, W, Haque, T

Get full text

415 TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN INCREASED SUSTAINED VIROLOGIC RESPONSE RATES IN TREATMENT-NAIVE PATIENTS REGARDLESS OF RACE OR ETHNICITY by Dusheiko, G.M, Fried, M.W, Reddy, R, Nelson, D.R, Bzowej, N, Adda, N, Wright, C.I, Bengtsson, L, George, S, Flamm, S.L

Get full text

299 BASELINE CHARACTERISTICS ASSOCIATED WITH PRESCRIPTION OF RIBAVIRIN >800 MG/DAY AMONG G2/3 PATIENTS PRESCRIBED PEGINTERFERON ALFA-2A (40KD) FROM REAL-WORLD PATIENT COHORTS: INTERIM RESULTS FROM PROPHESYS by Shiffman, M.L, Ferenci, P, Hassanein, T, Curescu, M, Coppola, C, Pruthi, J, Aires, R, Lengyel, G, Pol, S, Nelson, D, Messinger, D, Tietz, A, Dusheiko, G.M

Get full text

564 IMPACT OF ANTIVIRAL THERAPY ON GLOBAL CD8 T CELL DEFECTS IN CHRONIC HBV INFECTION by Lee, C.K, Khanna, P, Das, A, Matull, R, Han, K.J, Dusheiko, G.M, Maini, M.K

Get full text

565 IMPAIRED INNATE IMMUNE RESPONSES IN PATIENTS WITH EARLY ACUTE HBV INFECTION by Dunn, C, Brendish, N, Jones, M, Nebbia, G, Brown, D, Gilson, R.J, Dusheiko, G.M, Jacobs, M, Maini, M.K

Get full text

Transient elastography separates inactive HBV carriers from HBeAg minus disease by Maimone, S, Calvaruso, V, Pleguezuelo, M, Amaddeo, G, Squadrito, G, Raimondo, G, Dusheiko, G.M

Get full text

58 TREATMENT OF CHRONIC HEPATITIS C WITH TELAPREVIR (TVR) IN COMBINATION WITH PEGINTERFERON-ALFA-2A WITH OR WITHOUT RIBAVIRIN: FURTHER INTERIM ANALYSIS RESULTS OF THE PROVE2 STUDY by Dusheiko, G.M, Hezode, C, Pol, S, Goeser, T, Bronowicki, J.-P, Bourliere, M, Buggisch, P, Serfaty, L, Berg, T, Couzige, P, Benhamou, Y, Forestier, N, Bengtsson, L, Gharakhanian, S, Kauffman, R, Alam, J, Ferenci, P, Pawlotsky, J.-M, Zeuzem, S

Get full text

Treatment of small hepatocellular carcinomas by Dusheiko, G M, Hobbs, K E, Dick, R, Burroughs, A K

“…There is growing interest in screening to detect symptomless hepatocellular carcinoma (HCC), which should be easier to treat than symptomatic tumours. Combined…”
Get more information

Pathology of hepatitis C virus infection by Dhillon, A P, Dusheiko, G M

“…This paper reviews our current knowledge of hepatitis C virus, its structure, epidemiology and pathological effects in man. The histopathological features of…”
Get more information

HSV shedding by Sacks, S.L., Griffiths, P.D., Corey, L., Cohen, C., Cunningham, A., Dusheiko, G.M., Self, S., Spruance, S., Stanberry, L.R., Wald, A., Whitley, R.J.

“…Viral shedding of HSV occurs frequently in infected individuals. HSV is shed asymptomatically from multiple anatomical sites and shedding, like exposure, is a…”
Get full text

HSV-2 transmission by Sacks, S.L., Griffiths, P.D., Corey, L., Cohen, C., Cunningham, A., Dusheiko, G.M., Self, S., Spruance, S., Stanberry, L.R., Wald, A., Whitley, R.J.

“…A number of important risk factors for the acquisition of HSV-2 have been established including female gender, black or Hispanic ethnic origin, HIV infection,…”
Get full text

A rapid real-time quantitative polymerase chain reaction for hepatitis B virus by Brechtbuehl, K., Whalley, S.A., Dusheiko, G.M., Saunders, N.A.

“…Quantification of hepatitis B virus (HBV) DNA in serum is important for monitoring treatment. A rapid and cost effective alternative to the methods available…”
Get full text

DISTINCT FUNCTIONAL PATTERNS OF HBV-SPECIFIC CD8+ CELL RESPONSE IN HEPATITIS B VIRUS INFECTION by Webster, G.J.M, Reignat, S, Malacarne, P, Dusheiko, G.M

Get full text

HBV resistance following sequential antiviral prophylaxis for liver transplantation by Barnes, E.J., Brown, D., Patch, D., Dusheiko, G.M.

Get full text

369 The immunomodulatory effect of steroids in chronic hepatitis B by Gotto, J., Webster, G.J.M., Reignat, S., Jenkins, J., Mesogiti, D., Brown, D., Williams, R., Dusheiko, G.M., Bertoletti, A.

Get full text

Introduction: Is viral shedding a surrogate marker for transmission of genital herpes? by Sacks, S.L., Griffiths, P.D., Corey, L., Cohen, C., Cunningham, A., Dusheiko, G.M., Self, S., Spruance, S., Stanberry, L.R., Wald, A., Whitley, R.J.

“…Genital herpes, caused by either herpes simplex virus type 1 or 2 (HSV-1 and HSV-2), is a significant public health problem worldwide. It increases the risk of…”
Get full text

Tracking the source of the restored HBV-specific CD8 cell response during lamivudine therapy by Malacarne, F., Webster, G.J.M., Reignat, S., Ogg, G.S., Dusheiko, G.M., Vergani, D., Bertoletti, A.

Get full text

Clearance of acute hepatitis B IS associated with mutations in B and CTL epitopes of the core protein and the highly conserved region of the polymerase by Whalley, S.A., Brown, D., Jacobs, R., Webster, G.J.M., Hallett, R., Dusheiko, G.M., Teo, C.G.

Get full text